Conference Coverage

Flu and pneumonia vaccination tied to lower dementia risk


 

FROM AAIC 2020

Brain protective?

“Neither study can prove that the benefit is directly related to the vaccine itself, but what they can indicate is that potentially, vaccines are a way to protect your health and brain,” Dr. Edelmayer said.

In a statement, Maria Carrillo, PhD, chief science officer for the Alzheimer’s Association, noted that more research is needed.

The new data call “for further studies in large, diverse clinical trials to inform whether vaccinations as a public health strategy decrease our risk for developing dementia as we age,” Dr. Carillo said.

Funding for the influenza vaccine study was provided by the Christopher Sarofim Family Professorship in Biomedical Informatics and Bioengineering, a UT STARs Award, the Cancer Prevention and Research Institute of Texas, and the National Institutes of Health. Funding for the pneumonia study was provided by the National Institute on Aging. Dr. Amran, Dr. Ukraintseva, Dr. Edelmayer, and Dr. Carrillo have reported no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

COVID-19: Psychiatrists assess geriatric harm from social distancing
MDedge Neurology
Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease
MDedge Neurology
FDA okays first tau radiotracer to aid Alzheimer’s disease diagnosis
MDedge Neurology
Population study supports migraine–dementia link
MDedge Neurology
Five healthy lifestyle choices tied to dramatic cut in dementia risk
MDedge Neurology
Cognitive deficits complex in youths with type 2 diabetes
MDedge Neurology
Does moderate drinking slow cognitive decline?
MDedge Neurology
Move over supplements, here come medical foods
MDedge Neurology
Still no clear answer on intranasal insulin for MCI and Alzheimer’s disease
MDedge Neurology
Cardiovascular risk factors tied to midlife cognitive decline
MDedge Neurology